Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Benjamin Porter-Brown
Neutropenia During Tocilizumab Treatment Is Not Associated With Infection Risk in Systemic or Polyarticular-Course Juvenile Idiopathic Arthritis
Journal of Rheumatology
Rheumatology
Allergy
Immunology
Related publications
Growth During Tocilizumab Therapy for Polyarticular-Course Juvenile Idiopathic Arthritis: 2-Year Data From a Phase III Clinical Trial
Yearbook of Paediatric Endocrinology
Macrophage Activation Syndrome in Patients With Systemic Juvenile Idiopathic Arthritis Treated With Tocilizumab
Pediatric Rheumatology
Immunology
Pediatrics
Rheumatology
Allergy
Perinatology
Child Health
Rheumatoid Factor-Positive Polyarticular Juvenile Idiopathic Arthritis
A History Case of Tocilizumab Usage in a Patient With Systemic Juvenile Idiopathic Arthritis
Voprosy Sovremennoi Pediatrii - Current Pediatrics
Child Health
Pediatrics
Perinatology
Myositis in the Course of the Systemic Form Juvenile Idiopathic Arthritis
Reumatologia
Rheumatology
Allergy
Immunology
Polyarticular Juvenile Idiopathic Arthritis &Ndash; Epidemiology and Management Approaches
Clinical Epidemiology
Epidemiology
PReS-FINAL-1005: Hypertransaminasemia in Systemic Juvenile Idiopathic Arthritis During Anti-Interleukin 1 Treatment
Pediatric Rheumatology
Immunology
Pediatrics
Rheumatology
Allergy
Perinatology
Child Health
PReS-FINAL-2031: Hyaluronic Acid Is a Marker of Active Arthritis, but Not Systemic Inflammation in Systemic Juvenile Idiopathic Arthritis
Pediatric Rheumatology
Immunology
Pediatrics
Rheumatology
Allergy
Perinatology
Child Health
Biological Disease-Modifying Antirheumatic Drugs in Juvenile Idiopathic Arthritis of Polyarticular Course, Enthesitis-Related Arthritis, and Psoriatic Arthritis: A Consensus Statement
